Posts about:
AstraZeneca today announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub.
BARCELONA, Spain, April 27, 2022 /PRNewswire/ -- Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes. The initial focus of the partnership will be in European countries.
London office supports regional client needs and growing local team
Cape Town, South Africa, April 25, 2022 – Johnson & Johnson (the Company) today announced the launch of the J&J Satellite Center for Global Health Discovery (Satellite Center) at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, in Cape Town, South Africa. This marks the latest expansion of the J&J Centers for Global Health Discovery (J&J Centers), a global network of research collaborations between the Company and leading research institutions to accelerate translational and discovery research to address some of the world’s most pressing global health challenges. The Satellite Center at H3D will work to drive new solutions to address the present and rising threat of antimicrobial resistance (AMR) with a specific focus on multidrug-resistant Gram-negative bacteria (MDR-GNB).
SAINT CLOUD, Minn. - April 25, 2022 - Microbiologics, the foremost provider of biomaterials and contract microbiology research services, is pleased to announce the acquisition of Cryologics, a leader in cryopreservation of environmental isolates for use as quality control microorganisms. The procurement of Cryologics extends Microbiologics' capacity to serve QC microbiologists dedicated to the safety of pharmaceutical and personal care products.
WILMINGTON, N.C., April 21, 2022 - The PPD clinical research business of Thermo Fisher Scientific was named "Best Contract Research Organization" at the 15th annual Vaccine Industry Excellence (ViE) Awards during the 2022 World Vaccine Congress, recognizing its success in helping customers develop safe and effective vaccines to improve health and save lives.
$44 million facility increases production of single-use bioprocess containers that are critical to the development of new vaccines and therapies
-- Kite’s Global CAR T-Cell Therapy Manufacturing Network Increasing Capacity by 50% to Meet Patient Demand for New Cancer Therapies
Chicago, IL (April 14, 2022) – Advanced Clinical, a clinical development and strategic resourcing organization, is pleased to announce its continued expansion into Europe with the opening of a new office in Zug, Switzerland.
Basel, April 5, 2022 – Novartis today announced the U.S. Food and Drug Administration (FDA) has granted commercial licensure approval for its Durham, N.C. site, a multi-product gene therapy manufacturing facility. This approval allows the state-of-the-art, 170,000 square-foot facility to make, test and release commercial Zolgensma, as well as produce gene therapy product for current and future clinical trials.
